Checkpoint Therapeutics, Inc. Quarterly Operating Margin in % for Q4 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Checkpoint Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate for Q4 2023.
  • Checkpoint Therapeutics, Inc. Operating Margin for the quarter ending December 31, 2023 was -50.6K %.
  • Checkpoint Therapeutics, Inc. annual Operating Margin for 2023 was -50.6K %, a 66.6% decline from 2022.
Operating Margin, Quarterly (%)
Period Value YoY Chg Change % Start Date End Date
Q4 2023 -50.6K Oct 1, 2023 Dec 31, 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.